The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Comparison of adverse events beyond cycle 1 between cytotoxic combination and molecularly targeted phase I trials.

Emma J.  Jordan

No Relationships to Disclose

James F.  Spicer

Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Roche/Genentech

Speakers' Bureau - Lilly

Debashis  Sarker

Honoraria - Pfizer; Pfizer (I)

Consulting or Advisory Role - Baxalta; Blueprint Medicines; Eisai (I); Ipsen (I); Novartis

Travel, Accommodations, Expenses - Bayer; ipsen